156 related articles for article (PubMed ID: 2909617)
1. Alterations in the antigenic structure of two major HSV-1 glycoproteins, gC and gB, influence immune regulation and susceptibility to murine herpes keratitis.
Hendricks RL; Tao MS; Glorioso JC
J Immunol; 1989 Jan; 142(1):263-9. PubMed ID: 2909617
[TBL] [Abstract][Full Text] [Related]
2. The effect of cellular immune tolerance to HSV-1 antigens on the immunopathology of HSV-1 keratitis.
Hendricks RL; Epstein RJ; Tumpey T
Invest Ophthalmol Vis Sci; 1989 Jan; 30(1):105-15. PubMed ID: 2536358
[TBL] [Abstract][Full Text] [Related]
3. Cell-mediated immune tolerance to HSV-1 antigens associated with reduced susceptibility to HSV-1 corneal lesions.
Ksander BR; Hendricks RL
Invest Ophthalmol Vis Sci; 1987 Dec; 28(12):1986-93. PubMed ID: 2824400
[TBL] [Abstract][Full Text] [Related]
4. Identification of herpes simplex virus type 1 (HSV-1) glycoprotein gC as the immunodominant antigen for HSV-1-specific memory cytotoxic T lymphocytes.
Glorioso J; Kees U; Kümel G; Kirchner H; Krammer PH
J Immunol; 1985 Jul; 135(1):575-82. PubMed ID: 2582051
[TBL] [Abstract][Full Text] [Related]
5. Human natural killer cell recognition of herpes simplex virus type 1 glycoproteins: specificity analysis with the use of monoclonal antibodies and antigenic variants.
Bishop GA; Marlin SD; Schwartz SA; Glorioso JC
J Immunol; 1984 Oct; 133(4):2206-14. PubMed ID: 6206157
[TBL] [Abstract][Full Text] [Related]
6. Resolution of HSV corneal infection in the absence of delayed-type hypersensitivity.
Lausch RN; Kleinschradt WR; Monteiro C; Kayes SG; Oakes JE
Invest Ophthalmol Vis Sci; 1985 Nov; 26(11):1509-15. PubMed ID: 2997073
[TBL] [Abstract][Full Text] [Related]
7. Antigen presentation by Langerhans cells in vivo: donor-derived Ia+ Langerhans cells are required for induction of delayed-type hypersensitivity but not for cytotoxic T lymphocyte responses to alloantigens.
Peeler JS; Niederkorn JY
J Immunol; 1986 Jun; 136(12):4362-71. PubMed ID: 3519767
[TBL] [Abstract][Full Text] [Related]
8. Correlation of anterior chamber-associated immune deviation with suppression of corneal epithelial rejection in mice.
Yao YF; Inoue Y; Miyazaki D; Hara Y; Shimomura Y; Tano Y; Ohashi Y
Invest Ophthalmol Vis Sci; 1997 Feb; 38(2):292-300. PubMed ID: 9040461
[TBL] [Abstract][Full Text] [Related]
9. Herpes simplex virus (HSV) glycoproteins B and K inhibit cell fusion induced by HSV syncytial mutants.
Hutchinson L; Graham FL; Cai W; Debroy C; Person S; Johnson DC
Virology; 1993 Oct; 196(2):514-31. PubMed ID: 8396800
[TBL] [Abstract][Full Text] [Related]
10. Superiority of antibody versus delayed hypersensitivity in clearance of HSV-1 from eye.
Lausch RN; Monteiro C; Kleinschrodt WR; Oakes JE
Invest Ophthalmol Vis Sci; 1987 Mar; 28(3):565-70. PubMed ID: 3030956
[TBL] [Abstract][Full Text] [Related]
11. Structure-function analysis of herpes simplex virus glycoprotein B with fusion-from-without activity.
Roller DG; Dollery SJ; Doyle JL; Nicola AV
Virology; 2008 Dec; 382(2):207-16. PubMed ID: 18950828
[TBL] [Abstract][Full Text] [Related]
12. Cells expressing herpes simplex virus glycoprotein gC but not gB, gD, or gE are recognized by murine virus-specific cytotoxic T lymphocytes.
Rosenthal KL; Smiley JR; South S; Johnson DC
J Virol; 1987 Aug; 61(8):2438-47. PubMed ID: 3037106
[TBL] [Abstract][Full Text] [Related]
13. Contribution of virus and immune factors to herpes simplex virus type I-induced corneal pathology.
Hendricks RL; Tumpey TM
Invest Ophthalmol Vis Sci; 1990 Oct; 31(10):1929-39. PubMed ID: 2170289
[TBL] [Abstract][Full Text] [Related]
14. Role of macrophages in restricting herpes simplex virus type 1 growth after ocular infection.
Cheng H; Tumpey TM; Staats HF; van Rooijen N; Oakes JE; Lausch RN
Invest Ophthalmol Vis Sci; 2000 May; 41(6):1402-9. PubMed ID: 10798656
[TBL] [Abstract][Full Text] [Related]
15. Immunobiology of Langerhans cells on the ocular surface. II. Role of central corneal Langerhans cells in stromal keratitis following experimental HSV-1 infection in mice.
McLeish W; Rubsamen P; Atherton SS; Streilein JW
Reg Immunol; 1989; 2(4):236-43. PubMed ID: 2561960
[TBL] [Abstract][Full Text] [Related]
16. T cell subsets in the immune rejection of murine heterotopic corneal allografts.
Matoba AY; Peeler JS; Niederkorn JY
Invest Ophthalmol Vis Sci; 1986 Aug; 27(8):1244-54. PubMed ID: 2942516
[TBL] [Abstract][Full Text] [Related]
17. The dichotomy between herpes simplex virus type 1-induced ocular pathology and systemic immunity.
Metzger EE; Whittum-Hudson JA
Invest Ophthalmol Vis Sci; 1987 Sep; 28(9):1533-40. PubMed ID: 3040615
[TBL] [Abstract][Full Text] [Related]
18. Exacerbation of murine herpes simplex virus-mediated stromal keratitis by Th2 type T cells.
Jayaraman S; Heiligenhaus A; Rodriguez A; Soukiasian S; Dorf ME; Foster CS
J Immunol; 1993 Nov; 151(10):5777-89. PubMed ID: 8228262
[TBL] [Abstract][Full Text] [Related]
19. Monoclonal antibodies to the distinct antigenic sites on glycoproteins C and B and their protective abilities in herpes simplex virus infection.
Bystrická M; Petríková M; Zatovicová M; Soláriková L; Kostolanský F; Mucha V; Russ G
Acta Virol; 1997 Feb; 41(1):5-12. PubMed ID: 9199708
[TBL] [Abstract][Full Text] [Related]
20. A role for T lymphocytes in preventing experimental herpes simplex virus type 1-induced retinitis.
Whittum-Hudson J; Farazdaghi M; Prendergast RA
Invest Ophthalmol Vis Sci; 1985 Nov; 26(11):1524-32. PubMed ID: 3877027
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
